Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System

NCT01520545 is registered in ClinicalTrials.gov with Piramal Critical Care, Ltd. as lead sponsor.

NCT NCT01520545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01520545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Lead sponsor
Piramal Critical Care, Ltd.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2012
Completion date
October 31, 2016
Enrollment
153 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

severe spasticity